RxDoctor Payments Data

Lisa West, PA

Medical · Moore, OKNPI 1104896760

Payments from drug & device makers

$572in general payments, 2019–2025

Across 29 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$205
  • AstraZeneca$111
  • AbbVie$44
  • Genentech USA, Inc.$39
  • Otsuka America Pharmaceutical, Inc.$36
  • Novo Nordisk$36
  • plus $101 from 5 others

What the payments were for

  • Food & beverage$572100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$572 in reported general payments places this provider in the 55th percentile of 370 medical providers in Oklahoma.

See all medical providers in Oklahoma

Medicare billing

Part B allowed, 2024
$32,233
Medicare patients
85
Services billed
714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$63,308
JardianceEmpagliflozin13$23,117
Atorvastatin Calcium46$990
Rosuvastatin Calcium24$959
Albuterol Sulfate HfaAlbuterol Sulfate20$732
Amlodipine Besylate51$628
Glycopyrrolate13$612
Gabapentin25$491
Pantoprazole Sodium31$480
Levothyroxine Sodium37$463
Losartan Potassium30$450
Lisinopril39$406
Metoprolol Succinate23$348
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide18$346
Amitriptyline Hcl11$323

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$36$63,30845 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 370 medical providers in Oklahoma.

Other medical in Moore

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →